Omalizumab treatment in patients with cholinergic urticaria: A real-world retrospective study in Korea

被引：0
|
作者：
Choi, J. [1 ]
Kim, J. H. [2 ]
Park, H. [3 ]
Ye, Y. [3 ]
Shin, Y. S. [3 ]
Kang, H. [4 ]
Chung, S. J. [4 ]
机构：
[1] Hallym Univ, Dongtan Sacred Hosp, Hwaseong, South Korea
[2] Konyang Univ Hosp, Daejeon, South Korea
[3] Ajou Univ Hosp, Suwon, South Korea
[4] Seoul Natl Univ, Coll Med, Seoul, South Korea
来源：
ALLERGY | 2020年 / 75卷
基金：
新加坡国家研究基金会;
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
0346
引用
收藏
页码：436 / 437
页数：2
相关论文
共 50 条
  • [41] Real-World Experience on Omalizumab Treatment for Patients with Normocomplementemic Urticarial Vasculitis
    Liu, Taoming
    Bai, Juan
    Ying, Shuni
    Li, Sheng
    Pan, Yunlei
    Fang, Deren
    Qiao, Jianjun
    Fang, Hong
    JOURNAL OF ASTHMA AND ALLERGY, 2021, 14 : 433 - 437
  • [42] The real-world outcomes of vedolizumab in patients with ulcerative colitis in Korea: a multicenter retrospective study
    Ye, Byong Duk
    Cheon, Jae Hee
    Song, Ki Hwan
    Kim, Joo Sung
    Kim, Young-Ho
    Yoon, Hyuk
    Lee, Kang-Moon
    Kang, Sang-Bum
    Jang, Byung Ik
    Park, Jae Jun
    Kim, Tae Oh
    Lee, Dae-Wook
    Foo, Chee Yoong
    Shin, Jeong Eun
    Park, Dong Il
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2021, 14
  • [43] Retrospective Study on the Association of Biomarkers With Real-world Outcomes of Omalizumab-treated Patients With Allergic Asthma
    Kavati, Abhishek
    Zhdanava, Maryia
    Ortiz, Benjamin
    Lecocq, Jason
    Schiffman, Bradd
    Pilon, Dominic
    Ho, Harriet
    Lefebvre, Patrick
    Stone, Brian
    CLINICAL THERAPEUTICS, 2019, 41 (10) : 1956 - 1971
  • [44] Real-world characteristics and disease burden of patients with asthma prior to treatment initiation with mepolizumab or omalizumab: a retrospective cohort database study
    Llanos, Jean-Pierre
    Bell, Christopher F.
    Packnett, Elizabeth
    Thiel, Ellen
    Irwin, Debra E.
    Hahn, Beth
    Ortega, Hector
    JOURNAL OF ASTHMA AND ALLERGY, 2019, 12 : 43 - 58
  • [45] Real-world safety and effectiveness of omalizumab in Japanese patients with chronic spontaneous urticaria: A post-marketing surveillance study
    Hide, Michihiro
    Fukunaga, Atsushi
    Suzuki, Takayuki
    Nakamura, Noriko
    Kimura, Mine
    Sasajima, Takayoshi
    Kiriyama, Junna
    Igarashi, Atsuyuki
    ALLERGOLOGY INTERNATIONAL, 2023, 72 (02) : 286 - 296
  • [46] Adherence to omalizumab: A multicenter "real-world" study
    Campisi, Raffaele
    Crimi, Claudia
    Intravaia, Rossella
    Strano, Simona
    Noto, Alberto
    Foschino, Maria Pia
    Valenti, Giuseppe
    Viviano, Vittorio
    Pelaia, Corrado
    Ricciardi, Luisa
    Scichilone, Nicola
    Crimi, Nunzio
    WORLD ALLERGY ORGANIZATION JOURNAL, 2020, 13 (02):
  • [47] Severe asthma phenotypes in patients controlled with omalizumab: A real-world study
    Campo, Paloma
    Soto Campos, Gregorio
    Blanco Aparicio, Marina
    Moreira Jorge, Ana
    Gonzalez Exposito, Hector Manuel
    Quirce, Santiago
    Davila, Ignacio
    RESPIRATORY MEDICINE, 2019, 159
  • [48] Real-World Effectiveness of Omalizumab for the Treatment of Severe Asthma
    Tadrous, Mina
    Fernandes, Kimberly
    Khuu, Wayne
    Lebovic, Gerald
    Stanbrook, Matthew
    Martins, Diana
    Paterson, J. Michael
    Mamdani, Muhammad M.
    Juurlink, David N.
    Gomes, Tara
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 515 - 516
  • [49] Prevalence of omalizumab-resistant chronic urticaria and real-world effectiveness of dupilumab in patients with omalizumab-refractory chronic urticaria: a single-centre experience
    Zhu, Catherine
    BinJadeed, Hessah
    Gabrielli, Sofianne
    Prosty, Connor
    Rahme, Elham
    Shand, Greg
    Fein, Michael
    Ben-Shoshan, Moshe
    Netchiporouk, Elena
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024, 49 (10) : 1227 - 1231
  • [50] Omalizumab in chronic inducible urticaria: A retrospective, real-life study
    Fialek, M.
    Dezoteux, F.
    Le Moinga, A.
    Karimova, E.
    Ramdane, N.
    Pape, E.
    Azib-Meftah, S.
    Staumont-Salle, D.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2021, 148 (04): : 262 - 265
12345